The 340B Coalition
Presents


11th Annual 340B Coalition Conference
on Improving Access to Pharmaceutical Care and Ensuring
Compliance with Federal and State Laws


July 23-25, 2007
Marriott Wardman Park Hotel
Washington, DC
Co-Host:
 
 
340B Prime Vendor Program


This event has now concluded, however you can still purchase a CD of the presentations or a binder of all of the conference materials (more details below). Please join us next year for the 12th Annual 340B Coalition Conference
July 14-16, 2008 at the Omni Shoreham Hotel in Washington, DC.
Stay tuned to www.340bconferences.org for more details.
 
Overview
A conference designed for health care providers, the pharmaceutical industry, pharmacies, pharmacy service companies, government agencies, and other entities concerned about providing quality pharmaceutical care to low income and vulnerable populations while ensuring compliance with drug pricing laws.
 Introduction
Within the span of one month – from mid-December last year to mid-January this year – the federal government issued three proposed policies that, if implemented, would make sweeping changes to the 340B drug discount program and Medicaid rebate program. Among the changes under consideration are the following:
  • a narrowing of the patient populations eligible to receive discounted drugs from 340B providers;
  • an expansion of the number of pharmacies with which covered entities may contract to dispense 340B medications;
  • a change in the discount available to covered entities due to both Congressional and administrative adjustments to average manufacturer price (AMP) used to calculate 340B prices and Medicaid rebates;
  • reduced Medicaid reimbursement to covered entities, as well as new Medicaid rebate obligations for manufacturers, with respect to physician-administered drugs bought through 340B; and
  • the loss of nominal pricing for certain groups of safety net providers.
These changes are described in proposed regulations and guidelines published by the Health Resources and Services Administration (HRSA) and the Centers for Medicare and Medicaid Services (CMS).  As required by law, the parties affected by these proposals have had an opportunity to submit written comments and now the public awaits publication of the final versions of the proposed policies.

In addition to the three federal notices described above, a fourth guidance is expected to be published implementing a provision in the Deficit Reduction Act of 2005 (DRA) intending to add freestanding high-Medicaid children’s hospitals to the 340B program.  In the very near future, HRSA is expected to release the long-awaited notice describing how children’s hospitals can qualify for and enroll in the 340B program.  Growing demand for access to 340B discounts has motivated some members of Congress to consider 340B legislation that would add not only children’s hospitals but other safety net provider groups to the program.  Legislation introduced in the last Congress would have added, for example, critical access hospitals and federally-funded mental health and substance abuse clinics.  Anticipated legislation in 2007 would likely seek to add new groups of safety net providers to the program.  Such legislation would also try to tighten federal oversight of the 340B program to prevent diversion, overcharges and other potential violations that threaten program integrity.  Further changes to the Medicaid rebate and 340B discount formulas may also be established by Congress under legislation recently introduced by Senator Durbin (D-IL).

Against this backdrop of pending change, safety net providers, manufacturers and other program stakeholders are invited to a three-day conference in Washington, DC to focus on how to maximize the benefits of the 340B program while complying with program requirements. This event is co-hosted by the 340B Coalition and the 340B Prime Vendor Program. The 340B Coalition is a group of a dozen national associations that represent more than 12,000 health care providers and programs participating in the Federal 340B drug discount program. The 340B Prime Vendor Program is a special government procurement program established to increase the discounts already offered under Section 340B of the U.S. Public Health Service Act on outpatient covered drugs to all pariticipating hospitals, clinics and other HRSA grantees and is managed by Healthcare Purchasing Partners International. You will hear from key government officials who implement the 340B and Medicaid drug rebate programs, including HRSA regulators from the Office of Pharmacy Affairs (OPA) and Medicaid representatives from CMS and/or State Medicaid agencies. You will also hear from other government agencies about the latest investigatory and enforcement initiatives affecting 340B and Medicaid. Other speakers will include important legislative staff members who have played a role in implementation of the 340B program and other key pharmaceutical programs such as Medicare Part D and the Medicaid rebate program. This conference is unparalleled in providing timely information and relevant strategies for providers, government agencies, and industry on how to expand access to comprehensive pharmaceutical care, while complying with the complex array of drug pricing laws at both the Federal and State levels.

In response to feedback from prior conference attendees, the program will offer a separate track for stakeholders that are interested in learning more about how to implement and optimize the 340B Drug Pricing Program.   Attendees will here from covered entities, HRSA’s Office of Pharmacy Affairs, its Pharmacy Services Support Center and its Prime Vendor.  340B participation requires covered entities to adopt unique drug purchasing and inventory management systems which, in turn, may require infrastructure changes such as investment in new staff, split-billing software programs and other information system technologies.  This track will focus on practical solutions to the challenges of meeting 340B anti-diversion and Medicaid billing requirements.  Both vendors and covered entity representatives will describe their implementation models to help attendees identify and understand a “best practices” approach for their institution(s).  How to establish and effectively monitor a 340B contract pharmacy arrangement will also be explored in depth.

Finally, we plan to devote sessions at the conference to the future of pharmaceutical manufacturer patient assistance programs (PAPs) as well as the status of the Medicare Part D program. Both of these programs are key components to pharmaceutical access and we will provide the latest information about the implementation of Part D as well as the changing landscape of PAPs.

There will be continuing education credits for pharmacists.
 Who Should Attend
  • Pharmacists and clinic directors at institutions providing care to low-income and uninsured populations
  • Pharmaceutical manufacturers, wholesalers, GPO and pharmacy service industries
  • Retail, chain pharmacies, and other providers that contract with 340B entities
  • Part D and Medicare Advantage plans, PBMs, and other insurance companies
  • State Medicaid pharmacy directors and state pharmaceutical assistance program (SPAP) managers
  • AIDS Drug Assistance Program (ADAP) officials
  • AIDS service organizations
  • Consultants, attorneys and other compliance experts
  • Federal, state and local policy makers and government relations directors
  • Other providers of health care for the uninsured and vulnerable populations
 Agenda
View Conference Highlights and Agenda


Choose from two pre-conference workshops on the morning of July 23rd:

1) Introduction to the Federal 340B Drug Pricing Program
Learn all the basics about the 340B program.  Perfect for newcomers or those who need a refresher course. (more information)

2) Interface between the 340B and Medicaid Programs
Learn how these two crucial programs interface including how to bill correctly, avoiding duplicate discounts and other important compliance issues. (more information)

Continuing Education Credits for Pharmacists Available!

Comprehensive Pharmacy Services Continuing education credits for pharmacists will be made available for this conference.

Accreditation Council for Pharmacy Education (ACPE) continuing education credits provided by Comprehensive Pharmacy Services.
 Costs (Payments Must be Made Prior to the Conference)
Pre-Conference Workshop, July 23, 8:45 am to 1:00 pm*
and
Main Conference, July 23, 1:15 pm to July 25, 12:00 pm

Note: When registering you will have the option to select whether you want to attend the pre-conference workshop.

Registration Fees**
Affiliation
Pre-Conference Workshop
+
Main Conference
Main
Conference
Only
340B Coalition Members***
or
Government/Non-Profit Subscribers to the Federal Drug Discount and Compliance Monitor
or
Non-Profit Participants in the
340B Prime Vendor Program****
$749
$649
Non-Profit Health Care Providers/Government
$949
$799
Industry - Health or Pharmacy-Related Companies or Firms, Other Businesses
$1799
$1599
Industry Subscribers to the
Federal Drug Discount and Compliance Monitor
or
Contracted Suppliers of the
340B Prime Vendor Program****
$1649
$1449
*Please note that there will be a welcome reception and dinner limited to hospitals and SNHPA corporate partners on
Sunday, July 22, 2007 from 5:30-8:30 pm at the conference hotel.  There will be an additional cost of $50 to attend this
event and registration is required.

**Please note that early bird rates expired on June 8, 2007. Registration fees increased by $50, $100, $150, and $150
respectively after June 8, 2007.

***If you are unsure as to whether your institution is part of a 340B Coalition organization, please view the list of current 340B Coalition members at www.safetynetrx.org/public/340b_coalition.cfm.

****If you are unsure whether your organization/company is either a non-profit member of, or contracted suppler of, the 340B Prime Vendor Program, please visit www.340bpvp.com.
If you are not yet a subscriber to the Drug Discount Monitor, subscribe today and benefit from the discounted registration fee. More details at www.drugdiscountmonitor.com
 Registration
To register for this event, please click on the link below:

 Conference Binder/Presentations CD Orders
If you can not attend the conference but want to stay informed, you can purchase a conference binder or presentations CD by clicking on the Order Binder/CD link below.

Presentations CD (Contains Only Conference Presentations)
$100
Full Conference Binder for Government/Non-Profit Health Care Provider (Includes Presentations CD)
$200
Full Conference Binder for Industry - Health or Pharmacy-Related Companies or Firms, Other Businesses (Includes Presentations CD)
$250

(Binders/CDs can be ordered by credit card or check.)
 Sponsorship/Exhibition Opportunities
Attention pharmacy service companies, consultants, IT companies, pharmaceutical manufacturers, wholesalers, and GPOs!  Don't miss out on a great chance to promote your company's services and products to hundreds of pharmacists and other clinicians, hospital executives, federal, state and local government officials, GPO's, wholesalers, drug company decision makers and other leading health care professionals in an intimate and relaxed setting.  The exhibit area is designed to ensure a high level of traffic that will enable your company to maximize its marketing
investment.  There are many exciting sponsorship/exhibition options as well as opportunities to promote your services on our Web site.  More information on becoming a sponsor/exhibitor is available the Sponsors/Exhibitors page.
 Future Events
If you would like to be notified of future conferences on the 340B program, please join our conference notification mailing list (SNHPA members and Corporate Partners do not need to complete this form).
 

Thank you and we look forward to seeing you at the conference!
 
Sponsors/
Exhibitors
Top of Page

© Copyright 2007 Safety Net Hospitals for Pharmaceutical Access